LBRX

LB PHARMACEUTICALS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

LB PHARMACEUTICALS INC (LBRX) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$21.91M; the largest are Izzy Englander, Ken Griffin, Baker Bros. Advisors. This quarter: 1 added, 1 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · LowThis quarter · Quiet

Common-stock holders3

Congress trades0

Price$37.28vs quarter-end+14.87%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold1

Top holder

Izzy Englander

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $6.49M0.0% of portfolio200,0002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$6.49M	200,000	0.0%	Hold

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.